"As New Atlas points out, the Circulatronics platform starts with an injectable swarm of sub-cellular sized wireless electronic devices, or "SWEDs," which can travel into inflamed regions of the patient's brain after being injected into the bloodstream. They do so by fusing with living immune cells, called monocytes, forming a sort of cellular cyborg. After they've been injected, the SWEDs then follow the "natural trafficking" of the immune cells to sites of inflammation in the brain, which play a significant role in many neurological diseases."
"Once at the target area, the SWEDs embed in the inflamed part of the brain, where they deliver "electrical modulation" - basically tiny electrical shocks - in an effort to deliver signals that otherwise wouldn't get through. In their paper, the researchers claim Circulatronics could be used in the treatment of Alzheimer's, multiple sclerosis, strokes, brain tumors, spinal injuries, and more. The team says they've successfully implanted the experimental SWEDs in a rodent brain, which they could then control wirelessly to provide electrical stimulation."
Circulatronics is an autonomous bioelectronic implant platform that begins with an injectable swarm of subcellular wireless devices called SWEDs. SWEDs fuse with monocytes and follow natural immune-cell trafficking to inflamed brain regions. Once embedded, SWEDs deliver electrical modulation—tiny, targeted electrical pulses—to restore or alter signals in affected tissue. The platform targets neuroinflammatory conditions including Alzheimer's, multiple sclerosis, stroke, brain tumors, and spinal injuries. Demonstrations in rodents showed successful implantation and wireless control of SWEDs to provide electrical stimulation. The approach aims to offer a less invasive, more accessible alternative to surgically implanted brain interfaces.
#wireless-brain-implants #sweds-subcellular-devices #monocyte-mediated-targeting #neurological-disease-therapy
Read at Futurism
Unable to calculate read time
Collection
[
|
...
]